v3.20.1
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2018   57,968,493      
Beginning balance at Dec. 31, 2018 $ 705,009 $ 58 $ 957,631 $ (244,166) $ (8,514)
Increase (Decrease) in Stockholders' Equity          
Issuance of common stock in connection with settlement of restricted stock units, net of withholdings (in shares)   9,319      
Issuance of common stock in connection with settlement of restricted stock units, net of withholdings 0   0    
Exercise of stock options (in shares)   211,506      
Exercise of stock options 1,928   1,928    
Stock-based compensation expense 9,584   9,584    
Net loss (21,554)     (21,554)  
Foreign currency translation adjustment (372)       (372)
Ending balance (in shares) at Mar. 31, 2019   58,189,318      
Ending balance at Mar. 31, 2019 $ 694,595 $ 58 969,143 (265,720) (8,886)
Beginning balance (in shares) at Dec. 31, 2019 63,569,109 63,569,109      
Beginning balance at Dec. 31, 2019 $ 711,250 $ 63 1,197,379 (479,388) (6,804)
Increase (Decrease) in Stockholders' Equity          
Issuance of common stock in connection with settlement of restricted stock units, net of withholdings (in shares)   96,683      
Issuance of common stock in connection with settlement of restricted stock units, net of withholdings 0 $ 1 (1)    
Exercise of stock options (in shares)   37,275      
Exercise of stock options 384   384    
Stock-based compensation expense 20,870   20,870    
Net loss (60,106)     (60,106)  
Foreign currency translation adjustment $ (16,115)       (16,115)
Ending balance (in shares) at Mar. 31, 2020 63,703,067 63,703,067      
Ending balance at Mar. 31, 2020 $ 656,283 $ 64 $ 1,218,632 $ (539,494) $ (22,919)